ClariPi gets FDA nod for denoising technology

By AuntMinnie.com staff writers

June 27, 2019 -- Artificial intelligence (AI) firm ClariPi has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its AI-based CT denoising technology.

The company unveiled ClariCT.AI at RSNA 2018, showing that it uses a deep convolutional neural network trained with more than 1 million patient images to work in a vendor-neutral way to reduce noise and enhance image clarity for low-dose and ultra-low-dose DICOM CT images. The Clarity Engine is designed to separate image noise selectively while enhancing underlying structures, thus providing clarity-restored images.

ClariPi said the AI-based denoising technology potentially could enhance radiologists' reading confidence and enable accurate analysis for various imaging applications, including low-dose lung cancer screening CT.

ClariPI debuts AI CT software at RSNA 2018
ClariPI is debuting its new artificial intelligence (AI) software, ClariCT.AI, at RSNA 2018.

Copyright © 2019 AuntMinnie.com

Last Updated ks 6/27/2019 10:56:14 AM